Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2005-02-15
2005-02-15
Kunz, Gary (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C435S007200, C435S252300, C435S325000, C435S471000, C435S069100
Reexamination Certificate
active
06855807
ABSTRACT:
Opioid receptors form functional heterodimers with each other and with other G-protein coupled receptors, such as dopamine receptors, adrenergic receptors, or chemokine receptors. These receptors can be exploited for high throughput screening of compounds to identify heterodimer opioid receptor modulators (agonists and antagonists). The invention also relates to identification of novel heterodimer receptor ligands and synergistic compositions, which can provide strategies for analgesia, narcotic addiction, hypertension, HIV infection, and immune system function.
REFERENCES:
Egan TM and North RA. Science 214:923-924, 1981.*
Knapp et al. Molecular biology and pharmacology of cloned opiod receptors. FASEB J. Apr. 1995, vol. 9, pp. 516-525, see entire document, especially pp. 516-522 and Figures 4 and 5.
Sambrook et al. Molecular Cloning; a laboratory manual. 2nded. Cold Spring Harbor Press, 1989, pp. 17.2-17.44, see entire document.
Cvejic et al. Dimerization of the delta-opioid receptor: implication for a role in receptor internalization. J. biol. Chem., vol. 272. No. 43, pp. 26959-26964, 1997, see entire document.
Civelli et al. molecular Biology of the dopamine receptors. Eur. J. Pharmacol. 1991, vol. 207, pp. 277-286, especially pp. 278-280.
Ng, Gyc et al. Dopamine D2 receptor dimers and receptor-blocking peptides. Biochem. Biophys. Res. Comm. 1996, vol. 227, pp. 200-204.
Frielle et al. Properties of the B1- and B2-adrenergic receptor subtypes revealed by molecular cloning Clin. Chem. 1989, vol. 35, No. 5, pp. 721-725, see entire document.
Hebert et al. A peptide derived from b2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. 1996, vol. 271. No. 27, pp. 16384-16392, see entire document.
Power et al. Cloning and characterization of human chemokine receptors. Trends in Pharmacol. Sci. Jun. 1996, vol. 17, pp. 209-213, especillay Figure 2 and p. 212.
Rodriguez-Frade et al. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Mar. 1999, vol. 96, pp. 3628-3633, see entire document, especially Figure 1 and Figure 5.
Devi Lakshmi Arehole
Jordan Bryen Alexander
Darby & Darby
Kunz Gary
Landsman Robert
New York University
LandOfFree
Heterodimeric opioid G-protein coupled receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterodimeric opioid G-protein coupled receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterodimeric opioid G-protein coupled receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3486067